Literature DB >> 25897099

[Astrocytes in ischemic stroke - a potential target for neuroprotective strategies].

Bożena Gabryel1, Daniela Kasprowska1, Alicja Kost1, Krzysztof Łabuzek2, Tomasz Urbanek3.   

Abstract

Ischemic stroke is one of the leading causes of adult death and disability worldwide. Present applied therapeutic strategies do not give satisfactory results. It is often emphasized that pharmacological actions aimed at reducing the area of ischemic brain injury should protect astrocytes forming together with neurons and the endothelium neurovascular unit. Astrocytes contribute importantly to proper neuronal function during both physiological and pathological conditions. In ischemic stroke, astrocytes are involved in regulation of water and ion homeostasis, cerebral blood flow, maintenance of the blood-brain barrier, and control of the extracellular level of glutamate, as well as being a source of neuroprotectants. On the other hand, astrocytes may also contribute to enlarged ischemic area due to their participation in inflammatory processes and production of potential neurotoxic substances. Herein we review experimental and clinical data concerning adaptive and pathological roles of astrocytes during both early and late phases of ischemia. Especially, we emphasize specific features of astrocytes that might become a potential target of therapeutic strategies for ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25897099     DOI: 10.5604/17322693.1147866

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  4 in total

1.  Upregulation of glutamate metabolism by BYHWD in cultured astrocytes following oxygen-glucose deprivation/reoxygenation in part depends on the activation of p38 MAPK.

Authors:  Peng Yu; Li Guan; Lequan Zhou; Jianchao Guo; Ruixian Guo; Ruishan Lin; Wenting Ding; Xiaoying Li; Wei Liu
Journal:  Exp Ther Med       Date:  2017-04-12       Impact factor: 2.447

2.  Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following ischemic stroke via inhibition of LCN2.

Authors:  Yiming Deng; Duanduan Chen; Feng Gao; Hong Lv; Guojun Zhang; Xuan Sun; Lian Liu; Dapeng Mo; Ning Ma; Ligang Song; Xiaochuan Huo; Tianyi Yan; Jingbo Zhang; Zhongrong Miao
Journal:  J Biol Eng       Date:  2019-08-28       Impact factor: 4.355

3.  Astrocytic endothelin-1 overexpression promotes neural progenitor cells proliferation and differentiation into astrocytes via the Jak2/Stat3 pathway after stroke.

Authors:  Xiao Cheng; Patrick K K Yeung; Ke Zhong; Prince L M Zilundu; Lihua Zhou; Sookja K Chung
Journal:  J Neuroinflammation       Date:  2019-11-16       Impact factor: 8.322

4.  Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3.

Authors:  Yan Leng; Junyu Wang; Zhifei Wang; Hsiao-Mei Liao; Monica Wei; Peter Leeds; De-Maw Chuang
Journal:  Int J Neuropsychopharmacol       Date:  2016-08-12       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.